Citigroup Issues Autocallable Buffered Notes Linked to Emerging Markets Index with 21.9% Premium Potential

Structured Security Design Centered on Emerging Markets Performance

The securities represent a complex structured debt instrument issued by Citigroup Global Markets Holdings Inc. and fully guaranteed by parent company Citigroup Inc. Unlike conventional bonds, these notes do not pay periodic interest and do not guarantee repayment of principal at maturity. Instead, investor returns depend entirely on the performance of the MSCI Emerging Markets Index (ticker: MXEF) from the pricing date through maturity. The initial underlying value was established at 1,620.66, the closing value of the index on the July 17, 2026 pricing date.

The note structure incorporates three distinct return scenarios depending on when and how the securities are redeemed. The most favorable outcome for investors occurs if the index meets or exceeds its initial level on the first valuation date, triggering automatic early redemption. A middle-ground scenario preserves the stated principal amount if the index depreciates but remains above the final buffer value. The worst-case scenario applies if the index falls below the final buffer value of 1,377.561, exposing investors to losses exceeding their buffer protection of 15.00%.

Automatic Early Redemption Mechanism Offers Limited-Time Premium

A central feature of these securities is the automatic early redemption provision triggered on July 30, 2027, the first scheduled valuation date. If the MSCI Emerging Markets Index closing value on that date is greater than or equal to the initial underlying value of 1,620.66, the securities will be automatically redeemed three business days later. Investors holding automatically redeemed securities will receive $1,000 plus a 21.90% premium, equaling $1,219 per security held. This structure creates a natural incentive for investors to hope the underlying index remains stable or appreciates within the first year.

However, the disclosure emphasizes that this premium may be "significantly less than the appreciation of the underlying from the pricing date to the valuation date." Investors must recognize that the 21.90% premium is fixed and does not scale with larger index gains. If the index rallies substantially above its initial level by July 30, 2027, the fixed premium caps the investor's upside, while the issuer retains excess gains from hedging activities. Once automatically redeemed, securities cease to exist, eliminating any further participation in index appreciation.

Maturity Payoff Structure and Buffer Protection Limitations

If securities are not automatically redeemed and instead reach their final maturity date of July 21, 2028, investors face a three-tier payment structure. If the final underlying value exceeds or equals the initial value, investors receive $1,000 plus a return amount calculated by multiplying the underlying return by the 125.00% upside participation rate. For example, if the index appreciates 10% by maturity, investors would receive $1,000 plus ($1,000 × 0.10 × 1.25), totaling $1,125 per security. This 125% participation rate means investors benefit from index gains but not on a one-for-one basis.

The buffer protection activates only if the index declines. If the final underlying value falls below the initial value but remains at or above the final buffer value of 1,377.561 (representing an 85% level), investors receive exactly $1,000, preserving principal. The buffer protects against depreciation up to 15.00%. However, if the index falls below the final buffer value, the buffer protection deteriorates rapidly. The disclosure explicitly warns that "you will lose more than 1% of the stated principal amount of your securities at maturity for every 1% by which that depreciation exceeds the buffer percentage." This mathematical relationship means substantial losses are possible in severe market downturns.

Pricing, Underwriting Fees, and Estimated Valuation Variance

The offering was priced at $1,000 per security on July 17, 2026, generating gross proceeds of $5.377 million across 5,377 securities sold. Citigroup Global Markets Inc. (CGMI), acting as principal underwriter, charged a $15.00 underwriting fee per security, retaining $80,655 in total fees. J.P. Morgan Securities LLC and JPMorgan Chase Bank, N.A. acted as placement agents, receiving a $15.00 placement fee per security sold to non-fiduciary accounts from the underwriting fee pool. No fees are charged for sales to fiduciary accounts, resulting in a $985.00 net issue price for those investors.

A notable disclosure states that the estimated value of the securities on the pricing date is $975.20 per security—approximately $24.80 below the $1,000 issue price. Citigroup emphasizes this valuation is based on proprietary pricing models and internal funding rates, and "is not an indication of actual profit to CGMI or other of our affiliates, nor is it an indication of the price, if any, at which CGMI or any other person may be willing to buy the securities from you at any time after issuance." This disclosure suggests investors may face immediate negative unrealized returns if they attempt to sell shortly after purchase in secondary markets.

Liquidity and Credit Risk Considerations for Investors

The pricing supplement explicitly warns that the securities are not listed on any securities exchange and investors "must be willing to accept (i) an investment that may have limited or no liquidity and (ii) the risk of not receiving any amount due under the securities if we and Citigroup Inc. default on our obligations." The CUSIP 17334BDQ6 and ISIN US17334BDQ68 identify the securities in settlement systems, but no trading venue is designated. Investors seeking to exit their position before the automatic redemption date or maturity must negotiate directly with willing counterparties, a potentially difficult process in illiquid structured products.

All payments are subject to the credit risk of both Citigroup Global Markets Holdings Inc. and its parent, Citigroup Inc. While the guarantee from Citigroup Inc. technically provides a higher-quality obligor, the securities remain subordinated debt obligations with no FDIC insurance. In a severe credit stress scenario affecting Citigroup, investors could experience partial or total loss of their investment regardless of favorable index performance.

Index Performance Dependency and Valuation Date Mechanics

The success of this investment hinges entirely on MSCI Emerging Markets Index performance across two critical valuation dates: July 30, 2027, and July 18, 2028 (the final valuation date). The disclosure specifies that these dates are "each subject to postponement if such date is not a scheduled trading day or if certain market disruption events occur," introducing an element of uncertainty about when actual valuations occur. The closing value on each valuation date determines investor outcomes; the document does not explain how market disruption events are defined or how long postponements might extend.

The MSCI Emerging Markets Index comprises equity securities across emerging economies and represents a broad, diversified exposure to developing markets. However, emerging market indices are inherently volatile, subject to currency fluctuations, political events, and economic policy shifts in numerous countries. The initial underlying value of 1,620.66 represents a snapshot in time on the pricing date; investors must evaluate whether they believe the index will appreciate (for early redemption benefit or maturity upside), remain stable (triggering early redemption), or decline beyond the 15% buffer threshold (generating losses).

Hedging Activity and Profit Separation Between Issuer and Investors

The disclosure reveals that "in addition to the underwriting fee, CGMI and its affiliates may profit from hedging activity related to this offering, even if the value of the securities declines." This statement separates the economic interests of the issuer from those of the investor. Citigroup must hedge its obligations under the notes by purchasing index options and other derivative instruments; these hedging costs are embedded in the $24.80 gap between the $1,000 issue price and the $975.20 estimated value. If the issuer's hedging profits exceed anticipated levels, Citigroup benefits while investor returns remain capped.

This asymmetry is fundamental to structured product design. The issuer profits from favorable hedging outcomes and spreads, while investors receive only the returns specified in the terms. If emerging markets appreciate strongly between pricing and the first valuation date, Citigroup's hedges may generate significant gains beyond the 21.90% premium paid to investors. Conversely, if markets decline, the issuer's hedges limit losses while investors bear downside exposure beyond the buffer threshold.

Risk Factors and Total Loss Scenario

The document emphasizes early and often that "you may lose your entire investment in the securities." This warning is not rhetorical. If the MSCI Emerging Markets Index declines by more than 85% from its initial level of 1,620.66—falling below 1,377.561—the buffer offers diminishing protection. At 85% depreciation, an investor would lose approximately $250 per security. At 100% index depreciation (a highly adverse but theoretically possible scenario), losses would exceed $850 per security, approaching total capital loss.

Beyond index performance risk, investors face issuer credit risk and liquidity risk. The securities are unsecured obligations subordinated to senior debt of Citigroup. They are not FDIC-insured bank deposits and carry no governmental guarantee. Investors uncomfortable with concentrated exposure to emerging market equity performance, Citigroup credit quality, or illiquid structured products should avoid this offering. The prospectus supplement and product supplement contain additional risk disclosures and detailed terms not repeated in the pricing supplement.

Registration, Compliance Framework, and Document Integration

The securities were issued pursuant to Registration Statement Numbers 333-293732 and 333-293732-02, filed with the U.S. Securities and Exchange Commission. The pricing supplement was filed under Rule 424(b)(2), indicating a post-effective prospectus supplement following the effective registration statement. Investors are instructed to read the pricing supplement together with the product supplement (No. EA-02-12, dated February 25, 2026), underlying supplement (No. 13, dated February 25, 2026), prospectus supplement, and base prospectus (all dated February 25, 2026).

This multi-document structure ensures regulatory compliance but requires investors to synthesize information across multiple filings to understand the complete terms. The SEC has not approved or disapproved the securities or determined the truthfulness of disclosures; the standard SEC disclaimer applies. Investors should review all linked documents and consult with financial advisors before committing capital to structured products of this complexity.